What WeGuide does

WeGuide is an Australian digital health SaaS platform that provides modular patient engagement and clinical trial management software for research organizations, hospitals, and government health agencies. Built and operated by Melbourne-based parent Curve Tomorrow, the platform combines a no-code Program Builder, mobile and web applications, wearable integrations, telehealth, eConsent, biometric capture, and analytics dashboards to support randomized controlled trials, decentralized clinical trials, real-world evidence studies, observational research, patient registries, and population health programs. The architecture is multi-tenant and white-label, enabling customers to deploy branded apps into the Apple App Store and Google Play.

The product surface spans 14+ modules (Program Builder, Form Builder, eConsent, Patient Education, Screening, Multi-language, Wearables, Garmin Integration, Analytics, Integration Engine, Telehealth, Biometric Capture, eCOA, PREMs/PROMs) and 14+ purpose-built solutions covering RCT, DCT, RWE, observational, movement, wearable, genetic, citizen science, and employee wellbeing use cases. Native integrations connect to Garmin Health, Apple HealthKit, REDCap, EHRs, EMRs, EDCs, PAS systems, GIS, and genetic testing services. The platform holds TGA Class 1 medical device registration and a broad security certification stack (ISO 27001/27017/27018, SOC 2 Type II, SOC 3, CSA STAR Level 2, GDPR, HIPAA).

Revenue is generated through quote-based annual platform subscriptions, professional services for implementation, and white-label app licensing. Distribution is primarily direct enterprise sales supported by industry events and CRO/research partner referrals. Named customers include Murdoch Children's Research Institute (GEN V cohort study of 120,000 families), Western Health, Peter MacCallum Cancer Centre, Phoenix Australia, Mercy Health, Royal Melbourne Hospital, Royal Children's Hospital Melbourne, WA Country Health Service, PHN North Western, FSHD Global, and the World Health Organization. The company claims 200,000+ patients impacted across deployed applications and was featured in Apple Global Newsroom in 2023. The only disclosed external capital event is a 2021 investment from Australian Medical Angels.

Name

WeGuide

Legal name

WeGuide

Website

https://weguide.health

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

WeGuide is an Australian digital health SaaS platform that provides modular, white-label patient engagement and clinical trial software for hospitals, research institutes, government health agencies, and life sciences organizations globally.

Ownership category

akta.pro rank

Product category

Clinical Trial Patient Engagement Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)

akta.pro secondary industry

Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)

Keywords

• Patient engagement platform
• Clinical trial software
• Decentralized clinical trials
• ECOA eConsent solutions
• Digital health platform

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Platform Subscription: Subscription-based licensing of the WeGuide platform. Organizations pay to access the platform with modules and features configured to their needs. Pricing varies by organization size and study requirements.
2. Professional Services: Implementation support, onboarding assistance, and technical support services. The team guides organizations in translating workflows into optimal patient engagement configurations.
3. White-label / Branded App Licensing: Organizations can deploy their own branded apps in App Store and Google Play using the WeGuide platform infrastructure, with customization for organizational identity.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

WeGuide provides a regulatory-approved, modular patient engagement platform that enables clinical research teams, hospitals, and research institutes to build, brand, and deploy their own digital health apps for clinical trials, patient registries, real-world evidence studies, and telehealth programs. The platform combines a no-code Program Builder, eConsent, Form Builder, Wearables/Garmin/Apple HealthKit integrations, Telehealth, Integration Engine, and analytics dashboards, with white-label deployment under the customer's brand. Subscription-based SaaS pricing is complemented by professional services for implementation and configuration.

Product overview

WeGuide is a modular patient engagement platform built on 15+ years of experience with 100+ digital health solutions. The core platform serves both research (clinical trials, observational studies, RWE, DCTs, patient registries) and healthcare (patient engagement, telehealth, clinical interventions) sectors. Key modules include Program Builder (no-code protocol-to-program creation), Form Builder (custom surveys/questionnaires), eConsent (digital and dynamic consent), Patient Education, Screening, Wearables/Garmin Integration, Analytics, Integration Engine (connecting to EDCs, EHRs, EMRs), and Telehealth. The platform offers purpose-built solutions for Randomised Controlled Trials, Decentralised Clinical Trials, Real-World Evidence studies, Observational Research, Movement Studies, Wearable Device Studies, Genetic Research, Citizen Science, PREMs/PROMs, Patient Registries, Clinical Interventions, and Employee Wellbeing. Organisations can deploy whitelabel apps under their own brand with multi-language support, achieving up to 94% adherence rates and 200K+ patients impacted.

Differentiator

Problem solved

Functional benefit

Products and services

• WeGuide Patient Engagement Platform A regulatory-approved, modular patient engagement platform combining a no-code Program Builder, eConsent, Form Builder, Wearables integration, Integration Engine, Telehealth, and Analytics. It enables clinical research teams, hospitals, and research institutes to build, brand, and deploy their own digital health apps for clinical trials, patient registries, RWE studies, and telehealth programs under their own brand, with 200K+ patients engaged.

Quantifiable outcome

• 12x faster deployment: Platform ready in weeks instead of months, with changes made in minutes
• +5 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability5 records

Feature9 records

Partnerships

Six partnerships are on record, tiered core and strategic.

• GarmincoreTechnology or IntegrationNative integration partnership with Garmin Health API enabling seamless wearable data collection. WeGuide collects sleep, movement, cardiac data, heart rate, and HRV from Garmin devices without additional build work for researchers and healthcare organizations.
• ApplecoreTechnology or IntegrationIntegration with Apple Watch and HealthKit supported devices. WeGuide supports all HealthKit devices and was featured by Apple in Global Newsroom for heart failure study using Apple Watch ECG data collection.
• Curve TomorrowcoreOthersParent company and creator of WeGuide. Curve Tomorrow is a Melbourne-based digital health company that has built over 100 digital health products over the past decade, with WeGuide being their flagship patient engagement platform.
• World Health OrganizationstrategicStrategic or Co-development PartnerWHO listed as a customer/user of WeGuide platform for global health research initiatives and citizen science programs, indicating high-level institutional validation.
• Murdoch Children's Research InstitutestrategicStrategic or Co-development PartnerLong-term partner conducting the GEN V cohort study, collecting data from 120,000 families. MCRI uses WeGuide for patient registries, eConsent, and digital screening across multiple research programs.
• Western HealthstrategicStrategic or Co-development PartnerMajor healthcare partner using WeGuide for COVID-19 symptom tracking, employee wellbeing, and patient engagement programs. Multiple testimonials from Chief Medical Officer highlighting partnership value.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Withings Health Solutions: Withings Health Solutions provides connected device data and remote patient monitoring infrastructure to research and care programs, comparable to WeGuide's wearable integration capability (Garmin/Apple HealthKit modules).
• Evidation Health: Evidation operates a digital health engagement and real-world evidence platform leveraging consumer wearables and apps - comparable to WeGuide's wearable data and RWE focus, but more consumer-direct.

Broad incumbents

• Medidata (Dassault Systèmes): Medidata is a leading broad clinical trial technology platform (Rave, eCOA, DCT) from Dassault Systèmes, representing a larger incumbent competing with WeGuide across enterprise pharma trials.
• Veeva Systems: Veeva is a dominant cloud software provider for life sciences and clinical operations (CTMS, eTMF, Vault). It is a broad incumbent in the same enterprise clinical research software category that WeGuide plays in.
• Oracle Clinical One (formerly Siebel Clinical): Oracle Clinical One is a large, established clinical trial platform (EDC, eCOA, randomization) competing with WeGuide at the enterprise sponsor level across the full clinical trial workflow.

Direct peers

• Curebase: Curebase offers a decentralized clinical trial platform with virtual site operations, eConsent, and remote patient monitoring - overlapping with WeGuide's DCT and telehealth modules.
• Castor: Castor is a direct competitor offering a cloud platform for decentralized clinical trials, eConsent, ePRO, and remote patient monitoring. Overlaps heavily with WeGuide's core DCT, eConsent, and patient engagement capabilities for research sponsors.
• uMotif: uMotif is a patient-centric data capture platform for clinical trials and real-world studies with strong focus on ePRO and wearable integrations - directly comparable to WeGuide's patient engagement and DCT offerings.
• Clinical Ink (Signant Health): Clinical Ink / Signant Health delivers eCOA, eConsent, patient engagement, and wearable integration for clinical trials, serving as a near-direct competitor in regulatory-grade clinical trial technology.
• THREAD Research (now part of Definitive Healthcare): THREAD provides a purpose-built decentralized clinical trial platform with eCOA, telehealth, and patient engagement workflows - directly comparable to WeGuide's DCT solution and patient engagement software.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WeGuide